Search
People also search for:
About Us
Our Story
Aeobiome formulation
Aeobiome reimagines preventive healthcare through the lens of microbiome signalling. We are a team of scientists, clinicians and entrepreneurs united by a belief that real change starts at the gut – the nexus of immunity, metabolism and mind. Our platform is the first in India to offer clinically stable, patent-protected postbiotic solutions that integrate seamlessly into both digital ecosystems and physical products.
Our Values / Pillars
Evidence-Driven Discovery:
Every Aeobiome formulation is backed by peer-reviewed data. Scientific literature shows that short-chain fatty acids like butyrate reinforce intestinal mucosal defence by stimulating mucin production and promoting tight-junction assemblypmc.ncbi.nlm.nih.gov.
Clinician Collaboration:
More than 100 medical professionals contribute to our advisory network. Their insights shape our products and ensure clinical relevance.
Scalable Impact:
Through Aeon Formulations’ WHO-GMP facility, we manufacture at scale for hundreds of brands worldwide, guaranteeing quality and consistency.
Empowering Partnerships:
We license our intellectual property, offer white-label solutions and co-develop exclusive formulations to help partners bring validated postbiotic products to market.
Founders Note
At Aeobiome, we’re not selling a supplement. We’re pioneering a therapeutic signalling platform built on postbiotics, engineered for consistency, precision, and systemic reach.At Aeobiome, we are building a platform—not just a product—that integrates formulation science, mechanistic validation, and real-world clinical deployment.A ecosystem was designed where science, care, and data come together to guide real, lasting outcomes. What’s being built is more than a product—it’s a new rhythm for how prevention is lived, daily.”
Jayavardhini Sathiyamurthy - Biomedicine , MIB
Co - Founder / CEO
“A critical gap in chronic care delivery was identified—where gut-origin signalling was overlooked in systemic disease management. At Aeobiome, this gap has been addressed through the development of a stable, scalable postbiotic platform. Microencapsulated Trybutyrate has been positioned as a precision input, rather than a generic supplement.we’re building India’s first stable and scalable gut health platform—designed for doctors, backed by data, and driven by purpose.
Dr. Ariasudhan MD PHD
Founder / MD Aeobiome
